4.5 Review

Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis

Related references

Note: Only part of the references are listed.
Article Oncology

NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis

Emilly Schlee Villodre et al.

Summary: This study found that NDRG1 drives tumor progression and brain metastasis in aggressive breast cancers and NDRG1-high expression correlates with worse clinical outcomes.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Article Oncology

Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial

Min Yan et al.

Summary: This study investigated the activity and safety of pyrotinib plus capecitabine in patients with HER2-positive metastatic breast cancer and brain metastases. The combination therapy showed a high intracranial objective response rate in patients who had not received radiotherapy and had acceptable safety profiles.

LANCET ONCOLOGY (2022)

Review Oncology

Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer

Mohammad Azam Ansari et al.

Summary: miRNAs and nanotechnological strategies offer potential alternatives to overcome drug resistance in breast cancer treatment. Nanotechnology can enhance drug accumulation at tumor sites and reduce toxicity, while miRNAs can revert abnormal gene expression and serve as tumor suppressors. Therefore, the development of miRNA and nanodrug formulations is crucial for the effective management of breast cancer.

SEMINARS IN CANCER BIOLOGY (2021)

Article Oncology

Emerging Immunotherapies in the Treatment of Brain Metastases

Edwin Nieblas-Bedolla et al.

Summary: Brain metastases cause significant morbidity and mortality in cancer patients, with immunotherapies showing potential benefits in treatment but also facing challenges. Checkpoint inhibitors, chimeric antigen receptor T-cell therapy, and oncolytic viruses are considered potential options for treating brain metastases.

ONCOLOGIST (2021)

Review Oncology

Treatment strategies for breast cancer brain metastases

Caroline Bailleux et al.

Summary: Brain metastases from breast cancer are becoming more common and represent a major therapeutic challenge. Surgery and stereotaxic radiosurgery are effective for controlling BCBM.

BRITISH JOURNAL OF CANCER (2021)

Review Biochemistry & Molecular Biology

Targeting metastatic cancer

Karuna Ganesh et al.

Summary: Improved understanding of metastases biology has led to advancements in targeting and treating both micro- and macrometastases. Recent studies have identified the unique biology of metastasis-initiating cells, providing new opportunities for developing more effective treatment strategies through cancer sequencing, mechanistic studies, and clinical trials. These insights offer potential for better outcomes in targeting metastatic relapse and improving patient survival.

NATURE MEDICINE (2021)

Review Oncology

The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis

Markus Kuksis et al.

Summary: The study showed high incidence of brain metastases among patients with HER2+ and triple negative MBC, with lower incidence among patients with HR+/HER2- MBC. Further investigation is needed to assess the utility of brain metastases screening programs in these populations.

NEURO-ONCOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Editorial Material Oncology

Meningeal lymphatics prime tumor immunity in glioblastoma

Maya S. Graham et al.

Summary: A study published in Nature in 2020 challenges the notion of the brain as an immune-privileged organ by discovering functional lymphatic vessels in the meninges. These meningeal lymphatics are found to play an important role in sensing brain tumor antigens.

CANCER CELL (2021)

Article Oncology

Gain of HIF1 Activity and Loss of miRNA let-7d Promote Breast Cancer Metastasis to the Brain via the PDGF/PDGFR Axis

Christof B. Wyss et al.

Summary: Active HIF1 signaling and let-7d loss promote breast cancer brain metastasis through increased expression of PDGF, with pharmacologic inhibition of PDGFR suppressing brain metastasis and offering novel therapeutic opportunities for patients with this condition.

CANCER RESEARCH (2021)

Review Oncology

Exosomes and exosomal RNAs in breast cancer: A status update

Sreerenjini Lakshmi et al.

Summary: Exosomes and their RNA have potential roles in breast cancer biology and treatment, participating in breast cancer tumorigenesis and progression through the transfer of miRNAs and LncRNAs. The diagnostic and therapeutic applications of exosomal miRNAs/LncRNAs in breast cancer have been highlighted in numerous publications.

EUROPEAN JOURNAL OF CANCER (2021)

Review Biochemistry & Molecular Biology

Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer

Huimin Zhang et al.

Summary: The 2020 Nobel Prize in Chemistry was awarded to Emmanuelle Charpentier and Jennifer Doudna for their development of CRISPR/Cas9 gene editing technology, which has provided new tools for precise gene editing. This technology has been shown to be increasingly used in cancer research and treatment, achieving remarkable results in exploring tumorigenesis and development mechanisms.

MOLECULAR CANCER (2021)

Article Biochemistry & Molecular Biology

MiR-211 determines brain metastasis specificity through SOX11/NGN2 axis in triple-negative breast cancer

Jhih-Kai Pan et al.

Summary: The study identified high levels of miR-211 as a prognostic marker for breast cancer brain metastasis, enhancing trans-blood-brain barrier migration and adherence of tumor cells leading to brain colonization and poor survival outcomes. Furthermore, downstream targets of miR-211, SOX11 and NGN2, play a role in regulating TNBC brain metastasis.

ONCOGENE (2021)

Review Oncology

Breast Cancer Brain Metastasis-Overview of Disease State, Treatment Options and Future Perspectives

Chikashi Watase et al.

Summary: Brain metastases from breast cancer often occur in advanced stage patients with poor prognosis. Local treatments and new targeted therapies play crucial roles in improving clinical outcomes.

CANCERS (2021)

Review Clinical Neurology

Emerging principles of brain immunology and immune checkpoint blockade in brain metastases

Jawad Fares et al.

Summary: Brain metastases, the most common type of brain tumors, can be targeted via immunotherapy due to their immune microenvironment. Investigating the immunological intricacies of brain metastases has opened up potential for immune checkpoint inhibitors in treating this lethal disease, although the complex interactions between cancer cells and T cells in conferring resistance to therapy are still under investigation. Early trials with immune checkpoint inhibitors have shown clinical benefit in patients with brain metastases from melanoma and lung cancer, highlighting the potential of these treatments in improving outcomes.

BRAIN (2021)

Review Pharmacology & Pharmacy

Evolving new-age strategies to transport therapeutics across the blood-brain-barrier

Manisha Choudhari et al.

Summary: An understanding of the blood-brain barrier (BBB) is crucial for drug targeting to the brain, but challenges remain in treating brain diseases as traditional drugs struggle to cross the BBB.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Article Cell Biology

Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors

Roman Uzhachenko et al.

Summary: Inhibitors of cyclin-dependent kinases 4 and 6 (CDK4/6i) delay metastatic breast cancer progression, while also enhancing the efficacy of T cell-based therapies by inducing chemokines that recruit activated CD8(+) T cells to the tumor. The metabolic stress induced by CDK4/6i treatment in breast cancer cells plays a key role in this process, suggesting a link between tumor metabolic vulnerabilities and anti-tumor immunity.

CELL REPORTS (2021)

Article Immunology

A T-rojan horse strategy for cancer immunotherapy

Christine Rafie et al.

Science Immunology (2021)

Review Pharmacology & Pharmacy

The past, present, and future of breast cancer models for nanomedicine development

Paz Boix-Montesinos et al.

Summary: Despite recent advancements in nanomedicine for breast cancer treatment and promising results in pre-clinical models, clinical trials often face challenges. Innovative cell culture strategies and consideration of critical parameters for in vivo evaluation are essential to improve the clinical translation efficiency of nanomedicines in breast cancer treatment.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article

Molecular mediators of breast cancer metastasis

Ragini Yeeravalli et al.

Hematology/ Oncology and Stem Cell Therapy (2021)

Review Oncology

Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies

Yajie Wang et al.

Summary: Breast cancer brain metastasis is a common cause of death among breast cancer patients, with poor prognosis due to limited permeability of the blood-brain barrier and lack of effective treatments. While the sequence of metastasis events is accepted, the underlying mechanisms remain to be fully elucidated.

BRITISH JOURNAL OF CANCER (2021)

Article Biophysics

Breast adenocarcinoma-derived exosomes lower first-contact de-adhesion strength of adenocarcinoma cells to brain endothelial layer

Csilla Fazakas et al.

Summary: Brain metastases are a feared complication of cancer, with breast adenocarcinoma being one of the leading sources. Research shows that exosomes derived from breast adenocarcinoma can affect the adhesion strength between cancer cells and brain endothelium.

COLLOIDS AND SURFACES B-BIOINTERFACES (2021)

Review Oncology

The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies

Yogita Chhichholiya et al.

Summary: Breast cancer is a multifactorial, heterogeneous disease and metastasis is a major cause of death for patients. The metastatic cascade involves multiple stages, with therapeutic strategies focusing on targeting specific dysregulated genes and signalling pathways. Innovative treatments such as genome editing technologies are also being explored to improve treatment outcomes for stage IV/metastatic breast cancer.

MEDICAL ONCOLOGY (2021)

Review Oncology

The blood-tumour barrier in cancer biology and therapy

Patricia S. Steeg

Summary: The blood-brain barrier plays a crucial role in maintaining normal brain function, but modifications in primary brain tumors and brain metastases result in the blood-tumor barrier, further limiting the penetration of therapeutic agents. This challenge highlights the importance of understanding and overcoming the structural and functional complexities of the blood-tumor barrier for improving cancer therapy and patient outcomes.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Review Biotechnology & Applied Microbiology

Graphene-based nanomaterials for breast cancer treatment: promising therapeutic strategies

Guangman Cui et al.

Summary: This review highlights the potential applications of graphene-based nanomaterials (GBNs) in the treatment of breast cancer, including drug delivery, gene therapy, and phototherapy, showcasing their advantages in enhancing therapeutic effects, reducing toxicity, overcoming multidrug resistance, and inhibiting tumor metastasis.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Review Oncology

Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery

T. A. Arsiwala et al.

Summary: The blood-brain barrier (BBB) serves as a major barrier limiting drug passage into the brain, while the blood-tumor barrier (BTB) forms around tumors and remains effective in preventing chemotherapy delivery. Focused ultrasound is a noninvasive technique that can disrupt the BBB transiently, aiding in increased drug accumulation within targeted brain areas.

NEOPLASIA (2021)

Review Oncology

Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies

Alejandro Garcia-Alvarez et al.

Summary: Development of brain metastases is a significant event for patients with breast cancer, particularly those with HER2-positive tumors. Advances in targeted therapy against the HER2 receptor have improved management of HER2-positive breast cancer. Despite these improvements, brain metastases continue to be a challenge, highlighting the need for further research and innovative treatment strategies.

CANCERS (2021)

Review Oncology

Molecular Mechanisms Associated with Brain Metastases in HER2-Positive and Triple Negative Breast Cancers

Sarah Bryan et al.

Summary: Breast cancer is the most common malignant tumor among women globally and becomes incurable once it spreads to the brain. Approximately 30% of metastatic breast cancer patients develop brain metastases, with HER2-positive and triple-negative molecular subtypes being associated with an increased risk. Genetic and molecular mechanisms linked to these subtypes influence brain metastasis formation, presenting potential therapeutic strategies to prevent or slow progression.

CANCERS (2021)

Review Biochemistry & Molecular Biology

CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer

Desh Deepak Singh et al.

Summary: Breast cancer is the most common type of cancer in women worldwide, with triple-negative breast cancer having the highest mortality rate. The discovery of CRISPR/Cas9 technology offers hope for editing TNBC genomes and potentially serving as potent biomarkers in personalized medicine.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Review Oncology

Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: state of the art and future directions

Emanuela Ferraro et al.

Summary: The development of new generation HER2-targeted ADCs has transformed the treatment of HER2-positive breast cancer and re-energized drug development. These agents not only show great efficacy in traditional HER2-positive breast cancer, but also have the potential to be clinically valuable in cells with low HER2 expression or ERBB2 mutations.

BREAST CANCER RESEARCH (2021)

Review Oncology

Long noncoding RNAs in cancer metastasis

S. John Liu et al.

Summary: Long noncoding RNAs play crucial roles in promoting metastasis by participating in discrete pro-metastatic steps and influencing the metastatic tumor microenvironment. They have the potential for diagnostic and therapeutic applications, but also face controversies and ongoing technical challenges. Further research is needed to explore their mechanisms and potential as targets for novel therapies in cancer metastasis.

NATURE REVIEWS CANCER (2021)

Article Cell Biology

Meningeal lymphatic vessels regulate brain tumor drainage and immunity

Xueting Hu et al.

CELL RESEARCH (2020)

Review Medicine, Research & Experimental

Tumor microenvironment differences between primary tumor and brain metastases

Bernardo Cacho-Diaz et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy

Ranjana K. Kanchan et al.

MOLECULAR CANCER (2020)

Article Multidisciplinary Sciences

VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours

Eric Song et al.

NATURE (2020)

Article Medicine, General & Internal

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

R. K. Murthy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Oncology

Molecular and cellular mechanisms underlying brain metastasis of breast cancer

Mari Hosonaga et al.

CANCER AND METASTASIS REVIEWS (2020)

Article Biotechnology & Applied Microbiology

Exosomes Derived from Brain Metastatic Breast Cancer Cells Destroy the Blood-Brain Barrier by Carrying lncRNA GS1-600G8.5

Yunhe Lu et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Article Instruments & Instrumentation

Challenges in nanomedicine clinical translation

Josbert M. Metselaar et al.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)

Article Oncology

Evolving standards of care and new challenges in the management of HER2-positive breast cancer

Grace M. Choong et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Medicine, Research & Experimental

Genomic landscape of the immune microenvironments of brain metastases in breast cancer

Wei-cheng Lu et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Editorial Material Clinical Neurology

Breaking Down the Wall: The Strategic Plan of Cancer to Conquer the Brain

Manuel Valiente et al.

EPILEPSY CURRENTS (2020)

Article Oncology

The genomic landscape of breast cancer brain metastases: a systematic review

Alexander J Morgan et al.

LANCET ONCOLOGY (2020)

Review Biotechnology & Applied Microbiology

Emerging nanomedicines for effective breast cancer immunotherapy

Amirhossein Bahreyni et al.

JOURNAL OF NANOBIOTECHNOLOGY (2020)

Review Oncology

Brain immunology and immunotherapy in brain tumours

John H. Sampson et al.

NATURE REVIEWS CANCER (2020)

Review Oncology

The blood-brain barrier and blood-tumour barrier in brain tumours and metastases

Costas D. Arvanitis et al.

NATURE REVIEWS CANCER (2020)

Review Oncology

Local and systemic treatment for HER2-positive breast cancer with brain metastases: a comprehensive review

Wing-Lok Chan et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

Exosomes in cancer development, metastasis, and immunity

Lin Zhang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)

Article Oncology

Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases

Maria J. Sambade et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Review Cell Biology

Exosome-Mediated Metastasis: Communication from a Distance

Inbal Wortzel et al.

DEVELOPMENTAL CELL (2019)

Editorial Material Oncology

Brain metastases respond to neratinib plus capecitabine

Conor A. Bradley

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Review Immunology

CAR T cells for brain tumors: Lessons learned and road ahead

David Akhavan et al.

IMMUNOLOGICAL REVIEWS (2019)

Article Chemistry, Multidisciplinary

Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier via Transcytosis

Golnaz Morad et al.

ACS NANO (2019)

Article Multidisciplinary Sciences

Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel

Peng Guo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Medicine, General & Internal

Breast cancer

Nadia Harbeck et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Article Cell Biology

Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis

Goncalo Rodrigues et al.

NATURE CELL BIOLOGY (2019)

Review Physiology

BLOOD-BRAIN BARRIER: FROM PHYSIOLOGY TO DISEASE AND BACK

Melanie D. Sweeney et al.

PHYSIOLOGICAL REVIEWS (2019)

Article Biotechnology & Applied Microbiology

Method of establishing breast cancer brain metastases affects brain uptake and efficacy of targeted, therapeutic nanoparticles

Emily A. Wyatt et al.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)

Article Oncology

Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database

Yi-Jun Kim et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)

Article Medicine, Research & Experimental

Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer

Marni B. Siegel et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Biochemistry & Molecular Biology

STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis

Neibla Priego et al.

NATURE MEDICINE (2018)

Review Pharmacology & Pharmacy

Biogenesis and function of extracellular vesicles in cancer

Maarten P. Bebelman et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Article Multidisciplinary Sciences

Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases

Brunilde Gril et al.

NATURE COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

A molecular atlas of cell types and zonation in the brain vasculature

Michael Vanlandewijck et al.

NATURE (2018)

Article Multidisciplinary Sciences

Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption

Costas D. Arvanitis et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Oncology

Exosomal Annexin II Promotes Angiogenesis and Breast Cancer Metastasis

Sayantan Maji et al.

MOLECULAR CANCER RESEARCH (2017)

Review Biochemistry & Molecular Biology

Exosomes: From Garbage Bins to Promising Therapeutic Targets

Mohammed H. Rashed et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Medicine, Research & Experimental

JAK2-binding long noncoding RNA promotes breast cancer brain metastasis

Shouyu Wang et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Oncology

Brain Metastases in Newly Diagnosed Breast Cancer A Population-Based Study

Allison M. Martin et al.

JAMA ONCOLOGY (2017)

Review Biochemistry & Molecular Biology

Brain metastasization of breast cancer

Tania Custodio-Santos et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)

Article Oncology

Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis

Gail D. Lewis Phillips et al.

BREAST CANCER RESEARCH AND TREATMENT (2017)

Article Biochemistry & Molecular Biology

Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis

Adrienne Boire et al.

Article Multidisciplinary Sciences

Gene Expression Profiling of Breast Cancer Brain Metastasis

Ji Yun Lee et al.

SCIENTIFIC REPORTS (2016)

Review Oncology

Breast cancer brain metastases: biology and new clinical perspectives

Isabell Witzel et al.

BREAST CANCER RESEARCH (2016)

Review Oncology

Smart CARs engineered for cancer immunotherapy

Saul J. Priceman et al.

CURRENT OPINION IN ONCOLOGY (2015)

Article Genetics & Heredity

Nanoparticles coated with the tumor-penetrating peptide iRGD reduce experimental breast cancer metastasis in the brain

Amanda M. Hamilton et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2015)

Article Multidisciplinary Sciences

Structural and functional features of central nervous system lymphatic vessels

Antoine Louveau et al.

NATURE (2015)

Article Clinical Neurology

MTR-01BEVACIZUMAB-INDUCED MIF DEPLETION: A NOVEL RESISTANCE MECHANISM IN GLIOBLASTOMA

Brandyn Castro et al.

NEURO-ONCOLOGY (2015)

Article Biochemistry & Molecular Biology

nmiR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α

F. Xing et al.

ONCOGENE (2015)

Article Chemistry, Multidisciplinary

Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio

Tianzhi Yang et al.

PHARMACEUTICAL RESEARCH (2015)

Article Biotechnology & Applied Microbiology

Reduced graphene oxide induces transient blood-brain barrier opening: an in vivo study

Monique Culturato Padilha Mendonca et al.

JOURNAL OF NANOBIOTECHNOLOGY (2015)

Review Pharmacology & Pharmacy

Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody

William M. Pardridge

EXPERT OPINION ON DRUG DELIVERY (2015)

Review Pharmacology & Pharmacy

Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system

Muna Aryal et al.

ADVANCED DRUG DELIVERY REVIEWS (2014)

Article Endocrinology & Metabolism

Blood-brain barrier structure and function and the challenges for CNS drug delivery

N. Joan Abbott

JOURNAL OF INHERITED METABOLIC DISEASE (2013)

Article Radiology, Nuclear Medicine & Medical Imaging

64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer

Kenji Tamura et al.

JOURNAL OF NUCLEAR MEDICINE (2013)

Article Multidisciplinary Sciences

MicroRNA and Protein Profiling of Brain Metastasis Competent Cell-Derived Exosomes

Laura Camacho et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

Comprehensive molecular portraits of human breast tumours

Daniel C. Koboldt et al.

NATURE (2012)

Article Multidisciplinary Sciences

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Christina Curtis et al.

NATURE (2012)

Review Neurosciences

Structure and function of the blood-brain barrier

N. Joan Abbott et al.

NEUROBIOLOGY OF DISEASE (2010)

Article Multidisciplinary Sciences

Genes that mediate breast cancer metastasis to the brain

Paula D. Bos et al.

NATURE (2009)

Article Oncology

Brain metastases: The HER2 paradigm

Nancy U. Lin et al.

CLINICAL CANCER RESEARCH (2007)

Article Multidisciplinary Sciences

Molecular portraits of human breast tumours

CM Perou et al.

NATURE (2000)